Vervloet, Marc G.
de Jong, Hilda JI
Pander, Jan
Overbeek, Jetty A.
Funding for this research was provided by:
Astra Zeneca
Article History
Received: 19 June 2023
Accepted: 31 October 2023
First Online: 13 November 2023
Declarations
:
: All methods were performed in accordance with the relevant guidelines and regulations including the Declaration of Helsinki.
: The institutional review board of STIZON, Utrecht, Netherlands, approved the study and provided a waiver for informed consent to participate because only anonymized data from the PHARMO Data Network was used for this study.
: NA.
: JP is employee of AstraZeneca; HJ and JO are employees of the PHARMO Institute for Drug Outcomes Research. This independent research institute performs financially supported studies for government and related health care authorities and several pharmaceutical companies. MV does not have any competing interest.